DIRS.INFO The most relevant business & tech news

☆ Analysts predicted new obesity medicines would be blockbusters. Now they’re raising their forecasts
▼ + stars: | 2023-09-16 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +9 min

Fernandez sees a total addressable market of $140 billion to support patients with obesity. He expects there is a potential for GLP-1 drugs to become as common and widely used, much like statins are used to lower cholesterol. Morgan Stanley's Flynn estimates a 30% share of the diabetes market would generate $109 billion on a worldwide basis for GLP-1 drugs. Layer in a 15% to 30% share of the obesity market and that equates to worldwide sales of $97.4 billion to $194.8 billion. Guggenheim's estimates also assume that oral GLP-1 drugs that are currently in development are able to come to market a few years from now.

Persons: Seamus Fernandez, Fernandez, Lilly, Eli Lilly, Morgan Stanley, Terence Flynn, Eli Lilly's Mounjaro, Insulet, Canaccord, William Plovanic, Plovanic, It's, Morgan Stanley's Flynn, Flynn, Novo, Michael Bloom Organizations: Wall, Novo, American Heart Association, Food and Drug Administration, Novo Nordisk, Iqvia, Disease Control Locations: GLP

☆ Here’s what major analysts thought of the new iPhone and what to do with Apple’s stock
▼ + stars: | 2023-09-13 | by ( Samantha Subin | ) www.cnbc.com time to read: +4 min

He highlighted the enhanced photo capabilities on Pro models and called the new double tap feature the most notable upgrade to the Apple Watch. Many analysts expected hikes around $100 and $200 for the beefed up Pro and Pro Max iterations. Apple essentially delivered a $100 price hike on the Pro Max by doing away with the lower storage option. He noted that the hike on the Pro Max skewed to the low end of the Wall Street firm's expectation range. Evercore ISI's Amit Daryanani regarded the event as "mildly disappointing" for bulls hoping for a Pro price increase.

Persons: Toni Sacconaghi, Canaccord Genuity's Michael Walkley, Goldman Sachs, Michael Ng, Wells, Aaron Rakers, Pro Max, iPhones, Atif Malik, Evercore ISI's Amit Daryanani, David Vogt, Samik Chatterjee, Erik Woodring's, Morgan, Apple, Woodring, Sacconaghi, — CNBC's Michael Bloom Organizations: Apple, Apple Watch, Wall, Pro, Citi, UBS Locations: China

☆ Cannabis ETFs boom as HHS recommendation to ease restrictions raises hopes for federal reform
▼ + stars: | 2023-09-12 | by ( Stefan Sykes | ) www.cnbc.com time to read: +2 min

An employee of Aurora Deutschland GmbH, a manufacturer of medical Cannabis products, inspects a flowering Cannabis plant in a greenhouse in Leuna, Germany September 11, 2023. Marijuana-related ETFs are soaring in September as investors flood back into the sector after months of waning interest. It marked a swift turnaround for a quasi-legal industry curtailed by the anemic pace of federal reform. Last month's announcement also sent shares of several cannabis companies higher, including Canopy Growth, Tilray Brands and Cronos Group. At the time of the closure announcement, fund co-founder Morgan Paxhia told CNBC that it was not "immune to the broader macroeconomic environment and, more specifically, the dramatic shift in investor sentiment that has impacted the cannabis industry."

Persons: Canaccord, Matt Bottomley, Morgan Paxhia Organizations: Aurora Deutschland GmbH, U.S . Department of Health, Human Services, Dow Jones Industrial, Dow, Tilray Brands, Cronos Group, Marijuana, CNBC Locations: Leuna, Germany

☆ Bank of America says it's an official economic recovery now so history points to these stocks outperforming ahead
▼ + stars: | 2023-09-11 | by ( Alex Harring | ) www.cnbc.com time to read: +4 min

There appears to be an economic rebound taking place — and history shows ways to play it in the market, according to Bank of America. "It's official: we're in a Recovery," wrote strategist Savita Subramanian in a note to clients Sunday. An average recovery lasts nine months, though shorter durations seen in recent history raise concern that this one may not have staying power, she said. Still, the average analyst has a hold rating on the stock, according to LSEG. The average analyst has a hold rating on the stock, but price targets imply an upside of more than 7% on average.

Persons: Savita Subramanian, Subramanian, FactSet, Piper Sandler, John Barnidge, Barnidge, AIZ, Newell, Canaccord, Brian McNamara, McNamara, Molson Coors, Bud, Invesco, — CNBC's Michael Bloom Organizations: Bank of America, Wall, Newell Brands, LSEG, destocking, Anheuser, Busch InBev, Bud Light, TAP BUD, Molson Coors, Busch Inbev, Molson, ZOA Energy Locations: U.S

☆ The generative AI boom should have been Appen's time to shine. Here's what went wrong
▼ + stars: | 2023-09-06 | by ( Hayden Field | ) www.cnbc.com time to read: +13 min

For Appen, that would mean finding specialists in particular types of information that can bolster generative AI systems. Even before the generative AI transition, wages for Appen's data labelers were a sticking point. Kim Stagg, Appen's vice president of product, said the work required for generative AI services was different than what the company has needed in the past. "With generative AI, we see a different demand." The company's plunging stock price suggests that investors don't see the company's business offerings transferring to the generative AI space.

Persons: Jonathan Raa, Mike Monegan, he'd, Appen, it's, Armughan Ahmad, Mark Brayan, Ahmad, Monegan, he's, Appen's, Helen Johnson, Fab Dolan, Sujatha Sagiraju, Elena Sagunova, Jen Cole, Jukka Korpi, Still, OpenAI's, Google's Bard, didn't, Bard chatbot, Ed Stackhouse, raters, Erik Vogt, Vogt, hadn't, Kim Stagg, we've, Stagg, Lisa Braden, Harder, Canaccord Organizations: Nurphoto, Microsoft, Apple, Google, Amazon, Nvidia, Revenue, CNBC, Australian Securities Exchange, Adobe, U.S . National Labor Relations Board Locations: Seattle, Europe, Middle East, Africa

☆ 'Robot pills' could one day help patients avoid needles. The stocks are cheap, but risky
▼ + stars: | 2023-09-03 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +7 min

That's where a number of early-stage drug delivery companies come in — and most are flying under investors' radar. Drug delivery tends to be a "roll-up sector," explained Edward Nash, an analyst at Canaccord Genuity. Nash recently looked at four companies operating in drug delivery: Rani Therapeutics , Biora Therapeutics , Avalyn Pharma and Elektrofi. At the moment, the most effective GLP-1 medications for weight loss are delivered via a subcutaneous injection. The verstility of the Rani pill also is encouraging, according to Harrison, since it could be used with a wide range of drugs.

Persons: that's, Edward Nash, Nash, Rani, FactSet, Talat Imran, Eli Lilly, Evercore, Lilly, Genuity's Nash, Julian Harrison, Rani's, Harrison, Cantor Fitzgerald, Olivia Brayer, Imran, We're Organizations: Big Pharma, Therapeutics, Biora Therapeutics, Avalyn Pharma, CNBC, Novo Nordisk, Novo, European Union, Food and Drug Administration, Celltrion Locations: —

☆ Credit spreads are narrowing as the 10-year yield rises, says Canaccord Genuity's Tony Dwyer
▼ + stars: | 2023-08-23 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCredit spreads are narrowing as the 10-year yield rises, says Canaccord Genuity's Tony DwyerTony Dwyer, chief market strategist at Canaccord Genuity, and Roger Ferguson, former president and CEO of TIAA as well as the former Federal Reserve vice chairman, join 'Squawk on the Street' to discuss the lag effects of monetary policy, Powell's upcoming Jackson Hole speech, and the possibility of a soft landing.

Persons: Canaccord Genuity's Tony Dwyer Tony Dwyer, Roger Ferguson, Jackson Organizations: Federal Reserve

☆ Stocks making the biggest moves midday: SolarEdge Technologies, Humana, Starbucks, Robinhood and more
▼ + stars: | 2023-08-02 | by ( Michelle Fox | ) www.cnbc.com time to read: +4 min

SolarEdge Technologies — The solar stock tumbled about 19% after the company reported $991 million in revenue, missing analysts' estimates of $992 million, according to Refinitiv. CVS Health — The retail pharmacy stock gained 4% during midday trading Wednesday after the company posted strong earnings and revenue for the second quarter. The company reported adjusted earnings per share of $1.29, topping the $1.10 expected from analysts polled by StreetAccount. Starbucks' adjusted earnings per share for the fiscal third quarter was $1, versus the 95 cents expected by analysts, per Refinitiv. Chinese tech stocks — Shares of Chinese technology stocks dropped after regulators in China proposed limits on smartphone use for minors.

Persons: SolarEdge, Norwegian's, Emerson Electric's, Pinterest, Generac, Freshworks, Genuity, Robinhood, CNBC's Hakyung Kim, Pia Singh, Alex Harring Organizations: SolarEdge Technologies, CVS Health, CVS, Wall Street, Cruise, Susquehanna, Emerson, StreetAccount, Revenue, Wall, FactSet's, Starbucks, Bank of America, JPMorgan, Scotts Miracle, Gro, Scotts, JD.com, Baidu, Tencent Locations: Refinitiv, China

☆ This little-known software company could rally more than 35%, says Canaccord Genuity
▼ + stars: | 2023-08-02 | by ( Hakyung Kim | ) www.cnbc.com time to read: +1 min

Software-as-a-service company Freshworks has several positive catalysts ahead, according to Canaccord Genuity. He also increased his price target to $25 from $15. The new price target implies 37% upside from where shares closed on Tuesday. The company is "bringing it all together — [Go-to-market (GTM)] enhancements, operating efficiency, AI products and more," Hynes added. Freshworks' operating margins in the second quarter demonstrated significant upside and improved marketing and sales efficiency, Hynes said.

Persons: Freshworks, Canaccord, David Hynes, Hynes, Freddy Self, — CNBC's Michael Bloom Organizations: Service Locations: Freshworks

☆ Stocks making the biggest moves premarket: Match Group, CVS, SolarEdge and more
▼ + stars: | 2023-08-02 | by ( Pia Singh | ) www.cnbc.com time to read: +3 min

CVS Health — Shares of the retail pharmacy giant rose 1.8% premarket after the company posted strong earnings and revenue for the second quarter. CVS reported earnings of $2.21 per share on revenue of $88.9 billion. Wall Street analysts expected $2.11 per share on earnings of $86.5 billion, according to Refinitiv. AMD — The chip stock climbed more than 2% in premarket trading after the company posted better-than-expected second-quarter earnings and revenue. Match Group — The Tinder and Match parent jumped 10% on a strong second-quarter earnings report.

Persons: Kraft Heinz, Freshworks, Wall, David Hynes, BTIG, Macheel, Alex Harring, Yun Li, Jesse Pound, Samantha Subin, Brian Evans, Michelle Fox Theobald Organizations: CVS, Wall Street, Refinitiv, Norwegian Cruise, Susquehanna, Technologies, FactSet, AMD, Starbucks Locations: Norwegian, China

☆ Shares of these 2 global stocks could soar over 30% as bankruptcies begin to rise, analysts say
▼ + stars: | 2023-08-01 | by ( Ganesh Rao | ) www.cnbc.com time to read: +3 min

Company insolvencies are on the rise in Britain , and analysts are expecting two U.K.-based consultancies to be major beneficiaries. Earlier in the month, Begbies Traynor beat its rival and delivered a double-digit annual growth rate. Begbies Traynor Analysts expect Begbies Traynor's core insolvency division to benefit from rising U.K. insolvencies as economic conditions worsen. BEG-GB FRP-GB YTD line Analysts at Canaccord Genuity and Stifel echoed that view, saying that Begbies Traynor is strongly positioned, with over 80% of revenue derived from counter-cyclical insolvency services. The bank raised its forecasts for the firm's earnings for the rest of the year and expects FRP's stock to rise by 47% to £1.75.

Persons: Begbies Traynor, FRP, —, James Bayliss, Bayliss, Stifel, Sam Dindol, Berenberg Organizations: Bank of England, FRP, FRP Advisory Locations: Britain, United States, Canaccord

☆ Coinbase shares can rally more than 40% as crypto industry sees legal wins, Canaccord Genuity says
▼ + stars: | 2023-08-01 | by ( Pia Singh | ) www.cnbc.com time to read: +2 min

Canaccord Genuity sees a stronger future for Coinbase , doubling its price target on the company on the back of some wins for the crypto industry. The ruling places "further doubt" on the argument of the SEC's case against Coinbase, Vafi said. Coinbase reported earlier this year first-quarter revenue that was up 22% from the prior quarter. The crypto exchange's subscription and services revenue also came in at par with its trading revenue. Shares of Coinbase have gained more than 23% this month and are up nearly 194% year to date.

Persons: Canaccord Genuity, Joseph Vafi, Coinbase, Vafi, — CNBC's Michael Bloom Organizations: Coinbase, BTC, SEC, ETH

July 31 (Reuters) - New Relic (NEWR.N) said it has agreed to be taken private by TPG (TPG.O) and Francisco Partners in a $6.5 billion all-cash deal amid stiff competition in the application performance monitoring space from rival software companies Datadog and Dynatrace. New Relic's shares rose about 13% to $83.85 on Monday following the deal involving the private equity firms. New Relic reported annual revenue growth of about 18% compared with Dynatrace's (DT.N) 25% jump. New Relic on Monday reported first-quarter revenue of $242.6 million, compared with analysts' estimates of $239.2 million, according to Refinitiv IBES data. Qatalyst Partners is the company's financial adviser, while Morgan Stanley is the lead financial adviser for Francisco Partners and TPG.

Persons: Kingsley Crane, Genuity, Jana, Morgan Stanley, Akash Sriram, Zaheer Kachwala, Sriraj Kalluvila, Shounak Organizations: TPG, Francisco Partners, Francisco, New, Jana Partners, Eminence Capital, Qatalyst, Thomson Locations: ., Bengaluru

☆ Investors should be 'light and tight' on stocks, says Canaccord's Tony Dwyer
▼ + stars: | 2023-07-31 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailInvestors should be 'light and tight' on stocks, says Canaccord's Tony DwyerTony Dwyer, Canaccord Genuity Chief Market Strategist, joins 'Closing Bell: Overtime' to discuss markets and his takeaways from a busy earnings season.

Persons: Canaccord's Tony Dwyer Tony Dwyer, Canaccord

☆ Albemarle to take 5% stake in Patriot Battery Minerals for Canada lithium
▼ + stars: | 2023-07-31 | by ( ) www.reuters.com time to read: +2 min

Albemarle, the world's biggest lithium producer, is acquiring the stake in Patriot just as the Canadian company estimated its Corvette resource as the biggest hardrock lithium deposit in the Americas. Patriot also agreed to study with Albemarle the viability of a downstream lithium hydroxide plant integrated with its Corvette deposit. The battery metals miner on Monday announced the first mineral resource estimate for spodumene pegmatite at Corvette, which showed deposits of 109.2 million tonnes of lithium oxide. Albemarle will subscribe to about 7.1 million Patriot shares for C$15.29 apiece, a near 7% premium to the stock's July 31 closing price on the TSX Venture Exchange. Patriot's Australia-listed shares jumped as much as 20.7% to A$1.823 by 0053 GMT, posting their biggest intraday percentage gain since March 28.

Persons: pegmatite, Reg Spencer, Blair Way, Echha Jain, Melanie Burton, Subhranshu Sahu Organizations: Battery Metals, Albemarle, Canadian, Monday, TSX Venture Exchange, Patriot, Patriot's, Thomson Locations: Australia, Canada, Albemarle, Americas, Genuity, Patriot's Australia, Bengaluru, Melbourne

☆ Meta's stock just wrapped up its ninth straight monthly gain as Wall Street cheers cost cuts
▼ + stars: | 2023-07-31 | by ( Jonathan Vanian | ) www.cnbc.com time to read: +5 min

In this article META Follow your favorite stocks CREATE FREE ACCOUNTMark Zuckerberg, CEO, Meta Platforms, in July 2021. Kevin Dietsch | Getty Images News | Getty ImagesA year ago, Meta's stock was in the midst of a nosedive as Wall Street grew concerned that threats to the business were increasingly existential. Despite slipping on Monday, Meta's stock climbed 11% in July, wrapping up its ninth straight month of gains, by far the longest such stretch since Facebook's IPO in 2012. watch nowMeta has been the second-best performing stock in the S&P 500 this year, behind only Nvidia . Then came the cost cuts and Zuckerberg's promise early this year that 2023 would be the "year of efficiency."

Persons: Mark Zuckerberg, Kevin Dietsch, Mark Zuckerberg's, Zuckerberg, Frances Haugen, Haugen's Organizations: Meta, Getty, Facebook, Nvidia, Apple, Nurphoto Locations: Ukraine, Russia, China

Both Amazon and Alphabet will likely report their lowest-ever growth for the cloud computing business at 9.8% and 24.4%, respectively, according to analysts polled by Refinitiv. Meanwhile Microsoft Intelligent Cloud, home to Azure, is expected to grow at 13.7%, the slowest rate since 2017. The digital ad market recovery will also aid Alphabet, whose Google Search has so far avoided any meaningful market share loss to Microsoft's AI-powered Bing. Alphabet is expected to report 4.5% revenue growth in the April-June period, its best in three quarters. Microsoft and Alphabet will report quarterly results on July 25, Meta on July 26 and Amazon on Aug. 3.

Persons: Lucy Nicholson, Kingsley Crane, Rishi Jaluria, Jaluria, Bernstein, Yuvraj Malik, Aditya Soni, Shounak Dasgupta Organizations: Los Angeles , California U.S, REUTERS, Microsoft, Google, Refinitiv, RBC Capital, Facebook, Meta, BofA Global Research, Thomson Locations: Los Angeles , California, Bengaluru

☆ Electric helicopters could replace rideshares. How to invest in this 'evolutionary' technology
▼ + stars: | 2023-07-23 | by ( Alex Harring | ) www.cnbc.com time to read: +7 min

"It's more of an evolutionary technology than a revolutionary technology." But Cowen managing director Cai von Rumohr said investors should be prepared for timelines to be pushed back, as this is still considered "early-stage tech." "Given the push for climate and to basically reduce carbon emissions, I think, at some point, there's going to be a market," von Rumohr said. The outlook is still clouded by many variables, von Rumohr said. "It's definitely an important investment opportunity for investors," Moeller said.

Persons: Harry Potter, Austin Moeller, Moeller, Archer, Joby, Cowen, Cai von Rumohr, von Rumohr, Lilium, Von Rumohr, Marco Iachini, Vanda Research's, Bill Peterson, It's Organizations: Archer, Federal Aviation Administration, FAA, Toyota, Stellantis, Air Force, Aerospace, JPMorgan

☆ The one piece of news from Tesla’s earnings report that’s got analysts buzzing
▼ + stars: | 2023-07-20 | by ( Samantha Subin | ) www.cnbc.com time to read: +2 min

Tesla 's plan to share its full self-driving capabilities with original equipment manufacturers has Wall Street analysts talking. TSLA 1D mountain Tesla shares fall after second-quarter earnings The comments from Musk came after Tesla topped second-quarter earnings expectations but showed margin weakness due to recent price cuts. Despite these near-term margin concerns , Morgan Stanley's Adam Jonas highlighted the FSD commentary as his biggest takeaway from the call. He did, however, stress some logistical concerns, including whether Tesla would need "greater involvement" in full software system of its peers. "A potential licensing of FSD would represent an important change of scope in how investors measure the TAM for Tesla."

Persons: Tesla, Elon Musk, we're, Musk, Morgan Stanley's Adam Jonas, Jonas, Goldman Sachs, Mark Delaney, Evercore ISI's Chris McNally, Canaccord, George Gianarikas, — CNBC's Michael Bloom Organizations: Wall, TAM, Tesla

☆ Bitcoin’s chart shows a new cycle is taking hold and investors should make use of current sluggishness, says Canaccord Genuity
▼ + stars: | 2023-07-19 | by ( Tanaya Macheel | ) www.cnbc.com time to read: +2 min

He told investors to "utilize pending near-term weakness to add exposure near important technical support at their 50-day moving averages." Investors should expect the first level of resistance at about $30,493 on the upside and the next at $31,476, he said. Should the bitcoin price turn lower, first support would be at $28,717, about the level of its 50-day moving average. "This confirms the long-term trend is now up, a strong technical positive, and is consistent with a four-year cycle taking hold in cryptocurrencies," Mirza wrote. Lately, investors have been drawing similarities between the cryptocurrency's recent behavior and its moves in the lead up to the last halving.

Persons: Canaccord, Bitcoin, Javed Mirza, Canaccord Genuity, Mirza, bitcoin, CNBC's Michael Bloom Locations: cryptocurrencies

☆ Bitcoin investors are feeling deja vu as the setup for the next bull run takes shape
▼ + stars: | 2023-07-16 | by ( Tanaya Macheel | ) www.cnbc.com time to read: +5 min

The dollar index, which usually moves inversely with bitcoin, also hit its lowest level in more than a year last week, and bitcoin didn't budge. "It wasn't until the bitcoin halving a year later, in the spring of 2020, that we saw a market recovery transform into a sustained rally. Investors tend to expect seasonal gains in the fourth quarter, which has brought bitcoin a 93.38% return on average since 2013. The Ripple case also gives the industry hope that the SEC "takes its foot off of the enforcement pedal," Canaccord Genuity said. "Until the next difficulty adjustment, which will happen in about two weeks, miners' selling pressure will likely continue," Hasegawa added.

Persons: Bitcoin, bitcoin, pullbacks, Andrew Lawrence, Censo, Lawrence, it's, Cantor Fitzgerald, Canaccord Genuity, Chase White, they've, bitcoin's, Yuya Hasegawa, Hasegawa Organizations: BlackRock, SEC, Investors

☆ Coinbase shares surged on Ripple’s partial court victory this week. Why the decision matters for the crypto exchange
▼ + stars: | 2023-07-14 | by ( Tanaya Macheel | ) www.cnbc.com time to read: +3 min

Thursday's judgment was only a partial win for Ripple, but significant nonetheless for both the company and the wider crypto market. Coinbase shares rallied more than 24% the day of the ruling on optimism that it might prevail in its own battle with the SEC. Regulators in June sued Coinbase, alleging it was operating as a broker, an exchange and a clearinghouse for unregistered securities – and named 13 such securities. "In our view, [the] decision in the Ripple case helps tip the scale even more toward a favorable outcome for Coinbase." Needham has a buy rating on Coinbase and on Friday raised its price target to $120 from $70.

Persons: Coinbase, it's, Canaccord, Joseph Vafi, Vafi, Needham, John Todaro, Genuity, Raymond James, Berenberg, Cowen, Ramsey El Organizations: Labs, SEC, Regulators, Wedbush Securities, Berenberg, BTC, Coinbase, Barclays Locations: Coinbase

☆ Tesla's blistering rally continues after quarterly deliveries beat
▼ + stars: | 2023-07-03 | by ( Aditya Soni | ) www.reuters.com time to read: +2 min

[1/2] The Tesla logo is seen on a car in Los Angeles, California, U.S., July 9, 2020. REUTERS/Lucy Nicholson/File PhotoJuly 3 (Reuters) - Tesla (TSLA.O) shares jumped 6% on Monday after better-than-expected quarterly deliveries showed that Chief Executive Elon Musk's plan of boosting volumes through discounts was working. "Tesla's price cuts are working in a big way," said Gene Munster, managing partner at investment firm Deepwater Asset Management. The median price target on the stock stands at $210, which is about 20% below its last closing price. "Our money's on Elon," said Canaccord Genuity analyst George Gianarikas, who lifted his price target on Tesla by $36 to $293.

Persons: Lucy Nicholson, Elon Musk's, Gene Munster, Tesla, Bernstein, Toni Sacconaghi, Canaccord, George Gianarikas, Aditya Soni, Shounak Dasgupta Organizations: REUTERS, Asset Management, Thomson Locations: Los Angeles , California, U.S, Elon

☆ Tesla has long-term earnings power and strong demand, says Canaccord Genuity's George Gianarikas
▼ + stars: | 2023-07-03 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailTesla has long-term earnings power and strong demand, says Canaccord Genuity's George GianarikasCanaccord Genuity's George Gianarikas joins 'Squawk on the Street' to discuss Tesla's delivery performance, the A.I. impact on Tesla, and how Tesla's cost cutting measures are affecting its bottom line.

Persons: Tesla, Canaccord Genuity's George Gianarikas Canaccord, George Gianarikas

☆ Here's what analysts are saying after Tesla's second-quarter vehicle deliveries report
▼ + stars: | 2023-07-03 | by ( Brian Evans | ) www.cnbc.com time to read: +3 min

Tesla shares rose more than 6% in the premarket, giving Nasdaq-100 futures a boost . Goldman Sachs took the higher vehicle deliveries as a bullish signal. Canaccord's $293 price target implies about 12% upside for Tesla shares. Citi has a $215 per share price target on Tesla, a which the stock has already surpassed by more than 21%. Sacconaghi's $150 price target implies downside of more than 40% from Friday's close.

Persons: Tesla, FactSet, Goldman Sachs, Mark Delaney, Canaccord Genuity, George Gianarikas, Gianarikas, Itay Michaeli, Bernstein's Toni Sacconaghi Jr, Sacconaghi, Michael Bloom Organizations: Nasdaq, Tesla, Citi Locations: Friday's

Search resuls for: "Canaccord Genuity"

25 mentions found